These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7494116)

  • 21. Azelastine nasal spray in the management of seasonal allergic rhinitis.
    Meltzer EO; Weiler JM; Dockhorn RJ; Widlitz MD; Freitag JJ
    Ann Allergy; 1994 Apr; 72(4):354-9. PubMed ID: 7908778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the drug monitoring programme of azelastine hydrochloride nasal spray in the treatment of allergic rhinitis in children under 13 years of age.
    Wober W; Diez Crespo CD; Bähre M
    Arzneimittelforschung; 1997 Jul; 47(7):841-4. PubMed ID: 9272242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A dose-ranging study of the efficacy and safety of azelastine nasal spray in the treatment of seasonal allergic rhinitis with an acute model.
    Weiler JM; Meltzer EO; Benson PM; Weiler K; Widlitz MD; Freitag J
    J Allergy Clin Immunol; 1994 Dec; 94(6 Pt 1):972-80. PubMed ID: 7798545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vasomotor rhinitis: clinical efficacy of azelastine nasal spray in comparison with placebo.
    Gehanno P; Deschamps E; Garay E; Baehre M; Garay RP
    ORL J Otorhinolaryngol Relat Spec; 2001; 63(2):76-81. PubMed ID: 11244365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose related protective effect of azelastine on histamine induced bronchoconstriction in extrinsic asthma.
    Bauer K; Aurich R; Kaik G
    Int J Clin Pharmacol Ther Toxicol; 1990 Aug; 28(8):333-8. PubMed ID: 1980266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized double-blind placebo controlled study of azelastine nasal spray in children with perennial rhinitis.
    Herman D; Garay R; Le Gal M
    Int J Pediatr Otorhinolaryngol; 1997 Feb; 39(1):1-8. PubMed ID: 9051434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of azelastine 0.15% nasal spray and azelastine 0.10% nasal spray in patients with seasonal allergic rhinitis.
    Shah S; Berger W; Lumry W; La Force C; Wheeler W; Sacks H
    Allergy Asthma Proc; 2009; 30(6):628-33. PubMed ID: 19930788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of long-term efficacy and tolerability of azelastine nasal spray in the treatment of perennial allergic rhinitis.
    Gastpar H; Dorow P; Aurich R; Petzold U
    Arzneimittelforschung; 1993 Jul; 43(7):771-6. PubMed ID: 8103660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory effects of azelastine on nasal allergic responses in sensitized guinea pigs.
    Shirasaki H; Asakura K; Sohma S; Kataura A
    Eur Arch Otorhinolaryngol; 1992; 249(5):279-82. PubMed ID: 1381925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-allergic properties of a new histamine antagonist, 4-(p-chlorobenzyl)-2- [N-methyl-perhydroazepinyl-(4)]-1-(2H)-phthalazinone hydrochloride (azelastine).
    Tasaka K; Akagi M
    Arzneimittelforschung; 1979; 29(3):488-93. PubMed ID: 90510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histamine skin test reactivity following single and multiple doses of azelastine nasal spray in patients with seasonal allergic rhinitis.
    Pearlman DS; Grossman J; Meltzer EO
    Ann Allergy Asthma Immunol; 2003 Sep; 91(3):258-62. PubMed ID: 14533657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Azelastine nasal spray for allergic rhinitis.
    Med Lett Drugs Ther; 1997 May; 39(1000):45-7. PubMed ID: 9150688
    [No Abstract]   [Full Text] [Related]  

  • 33. Duration of the effect of a single dose of azelastine on histamine-induced bronchoconstriction.
    Magnussen H; Reuss G; Jörres R; Aurich R
    J Allergy Clin Immunol; 1989 Feb; 83(2 Pt 1):467-71. PubMed ID: 2563744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Azelastine hydrochloride: a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability.
    Bernstein JA
    Curr Med Res Opin; 2007 Oct; 23(10):2441-52. PubMed ID: 17723160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis.
    Berger W; Hampel F; Bernstein J; Shah S; Sacks H; Meltzer EO
    Ann Allergy Asthma Immunol; 2006 Sep; 97(3):375-81. PubMed ID: 17042145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seasonal rhinitis and azelastine: long- or short-term treatment?
    Ciprandi G; Ricca V; Passalacqua G; Truffelli T; Bertolini C; Fiorino N; Riccio AM; Bagnasco M; Canonica GW
    J Allergy Clin Immunol; 1997 Mar; 99(3):301-7. PubMed ID: 9058684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of azelastine 0.15% nasal spray administered once daily in subjects with seasonal allergic rhinitis.
    van Bavel J; Howland WC; Amar NJ; Wheeler W; Sacks H
    Allergy Asthma Proc; 2009; 30(5):512-8. PubMed ID: 19747429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative efficacy and safety of azelastine and levocabastine nasal sprays in patients with seasonal allergic rhinitis.
    Falser N; Wober W; Rahlfs VW; Baehre M
    Arzneimittelforschung; 2001; 51(5):387-93. PubMed ID: 11413739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy of topical azelastine in the treatment of allergic rhinitis caused by Parietaria officinalis].
    Pacor ML; Biasi D; Carletto A; Maleknia T; Lunardi C
    Recenti Prog Med; 1998 Apr; 89(4):177-9. PubMed ID: 9612009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Azelastine nasal spray as adjunctive therapy to azelastine tablets in the management of seasonal allergic rhinitis.
    Weiler JM; Meltzer EO
    Ann Allergy Asthma Immunol; 1997 Oct; 79(4):327-32. PubMed ID: 9357378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.